293 related articles for article (PubMed ID: 32249459)
1. Long noncoding RNAs in osteosarcoma via various signaling pathways.
Han J; Shen X
J Clin Lab Anal; 2020 Jun; 34(6):e23317. PubMed ID: 32249459
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F
J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
[TBL] [Abstract][Full Text] [Related]
3. The critical roles of lncRNAs in the development of osteosarcoma.
Ghafouri-Fard S; Shirvani-Farsani Z; Hussen BM; Taheri M
Biomed Pharmacother; 2021 Mar; 135():111217. PubMed ID: 33433358
[TBL] [Abstract][Full Text] [Related]
4. Downregulation of long non-coding RNA DBH-AS1 inhibits osteosarcoma progression by PI3K-AKT signaling pathways and indicates good prognosis.
Liu ZB; Wang JA; Lv RQ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1418-1427. PubMed ID: 30840262
[TBL] [Abstract][Full Text] [Related]
5. HIF‑1α‑induced upregulation of lncRNA UCA1 promotes cell growth in osteosarcoma by inactivating the PTEN/AKT signaling pathway.
Li T; Xiao Y; Huang T
Oncol Rep; 2018 Mar; 39(3):1072-1080. PubMed ID: 29328452
[TBL] [Abstract][Full Text] [Related]
6. LncRNA AWPPH promotes osteosarcoma progression via activation of Wnt/β-catenin pathway through modulating miR-93-3p/FZD7 axis.
Li C; Wang F; Wei B; Wang L; Kong D
Biochem Biophys Res Commun; 2019 Jun; 514(3):1017-1022. PubMed ID: 31092328
[TBL] [Abstract][Full Text] [Related]
7. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway.
Dong Y; Liang G; Yuan B; Yang C; Gao R; Zhou X
Tumour Biol; 2015 Mar; 36(3):1477-86. PubMed ID: 25431257
[TBL] [Abstract][Full Text] [Related]
8. LncRNA FER1L4 induces apoptosis and suppresses EMT and the activation of PI3K/AKT pathway in osteosarcoma cells via inhibiting miR-18a-5p to promote SOCS5.
Ye F; Tian L; Zhou Q; Feng D
Gene; 2019 Dec; 721():144093. PubMed ID: 31473323
[TBL] [Abstract][Full Text] [Related]
9. [Long Non-Coding RNAs as Competitive Endogenous RNAs in Osteosarcoma].
Kushlinskii NE; Fridman MV; Braga EA
Mol Biol (Mosk); 2020; 54(5):776-801. PubMed ID: 33009789
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of FER1L4 promotes the apoptosis and suppresses epithelial-mesenchymal transition and stemness markers via activating PI3K/AKT signaling pathway in osteosarcoma cells.
Ma L; Zhang L; Guo A; Liu LC; Yu F; Diao N; Xu C; Wang D
Pathol Res Pract; 2019 Jun; 215(6):152412. PubMed ID: 31000382
[TBL] [Abstract][Full Text] [Related]
11. HIF-1α induced long noncoding RNA FOXD2-AS1 promotes the osteosarcoma through repressing p21.
Ren Z; Hu Y; Li G; Kang Y; Liu Y; Zhao H
Biomed Pharmacother; 2019 Sep; 117():109104. PubMed ID: 31228799
[TBL] [Abstract][Full Text] [Related]
12. Application of Long Noncoding RNAs in Osteosarcoma: Biomarkers and Therapeutic Targets.
Li Z; Dou P; Liu T; He S
Cell Physiol Biochem; 2017; 42(4):1407-1419. PubMed ID: 28715796
[TBL] [Abstract][Full Text] [Related]
13. Molecular Mechanisms and microRNAs in Osteosarcoma Pathogenesis.
Kushlinskii NE; Fridman MV; Braga EA
Biochemistry (Mosc); 2016 Apr; 81(4):315-28. PubMed ID: 27293089
[TBL] [Abstract][Full Text] [Related]
14. LncRNA LINC00628 overexpression inhibits the growth and invasion through regulating PI3K/Akt signaling pathway in osteosarcoma.
He R; Wu JX; Zhang Y; Che H; Yang L
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5857-5866. PubMed ID: 30280767
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA PVT1 promotes osteosarcoma development by acting as a molecular sponge to regulate miR-195.
Zhou Q; Chen F; Zhao J; Li B; Liang Y; Pan W; Zhang S; Wang X; Zheng D
Oncotarget; 2016 Dec; 7(50):82620-82633. PubMed ID: 27813492
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2.
Gu W; Zhang E; Song L; Tu L; Wang Z; Tian F; Aikenmu K; Chu G; Zhao J
Biomed Pharmacother; 2018 Oct; 106():890-895. PubMed ID: 30119259
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA OIP5-AS1 mediates resistance to doxorubicin by regulating miR-137-3p/PTN axis in osteosarcoma.
Sun X; Tian C; Zhang H; Han K; Zhou M; Gan Z; Zhu H; Min D
Biomed Pharmacother; 2020 Aug; 128():110201. PubMed ID: 32460190
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of long non-coding RNA ITGB2-AS1 inhibits osteosarcoma proliferation and metastasis by repressing Wnt/β-catenin signalling and predicts favourable prognosis.
Dai J; Xu LJ; Han GD; Jiang HT; Sun HL; Zhu GT; Tang XM
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S783-S790. PubMed ID: 30260245
[TBL] [Abstract][Full Text] [Related]
19. LncRNA BE503655 inhibits osteosarcoma cell proliferation, invasion/migration via Wnt/β-catenin pathway.
Huang Q; Shi SY; Ji HB; Xing SX
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31316000
[No Abstract] [Full Text] [Related]
20. Targeting XIST induced apoptosis of human osteosarcoma cells by activation of NF-kB/PUMA signal.
Gao W; Gao J; Chen L; Ren Y; Ma J
Bioengineered; 2019 Dec; 10(1):261-270. PubMed ID: 31189404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
